MAPT and Alzheimer disease: In addition, a study of mice injected with β-amyloid peptide 1–42 into the brain to induce Alzheimer’s disease showed that they had decreased hyperphosphorylated tau protein following the administration of melatonin, resulting in improved neuronal viability [9].